427 filings
Page 4 of 22
8-K
tjznc33 x6lwe
3 Nov 21
Results of Operations and Financial Condition
7:30am
8-K
7cmc8x1jf u7
4 Aug 21
Second-Quarter Revenue of $914.6 Million
7:30am
SD
vnfoga77ob64u5ek6o
28 May 21
Conflict minerals disclosure
6:05am
8-K
u4n6naj28j55swg u9
18 May 21
Amended and Restated Employment Agreement
4:16pm
8-K
p81fb9ed
10 May 21
Submission of Matters to a Vote of Security Holders
5:19pm
S-3ASR
ukr60vy 27
4 May 21
Automatic shelf registration
4:28pm
8-K
5yld1
4 May 21
Results of Operations and Financial Condition
7:30am
8-K
oanwhmcw7
23 Apr 21
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
4:01pm
8-K
e1eazf
29 Mar 21
Charles River Laboratories Completes the Acquisition of Cognate Bioservices
5:18pm
8-K
1oozvr
23 Mar 21
Charles River Laboratories Announces Closing of Senior Notes Offering
4:42pm
8-K
a617dfh nzinpu0
9 Mar 21
Charles River Laboratories Announces Planned Offering of $1 Billion of Senior Notes
8:59am
8-K
nc074kqmyrjkiy3tce85
17 Feb 21
Entry into a Material Definitive Agreement
4:03pm
8-K
e9r67ajvpvsqsrgvu
17 Feb 21
Results of Operations and Financial Condition
7:30am
UPLOAD
l28 tnr8rqj
31 Dec 20
Letter from SEC
12:00am
CORRESP
2b9s s2g88oh6k03
17 Dec 20
Correspondence with SEC
12:00am
UPLOAD
pn4hmd1
7 Dec 20
Letter from SEC
12:00am